FdaApplication
NDA 208264
Identifiers
- fda_app_no: NDA208264
Properties
| Property | Value |
|---|---|
| applicant_name | ADIENNE SA |
| application_type | NDA |
| approval_date | 2017-01-26 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TEPADINA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
| TEPADINA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
| TEPADINA AND SODIUM CHLORIDE | THIOTEPA | 400MG | POWDER;INTRAVENOUS |
| TEPADINA AND SODIUM CHLORIDE | THIOTEPA | 200MG | POWDER;INTRAVENOUS |
4 products